CLDI analyst estimates
Calidi Biotherapeutics (CLDI) analyst ratings, the average price target and its range, and every firm's latest call.
- 0 firms rate CLDI: 0 buy, 0 hold, 0 sell.
- The average price target is $5.50 from None analysts, from $2.00 to $9.00.